Isolde Laukien Net Worth

The estimated Net Worth of Isolde Laukien is at least $992 Milión dollars as of 22 September 2009. Isolde Laukien owns over 3,000,000 units of Bruker Corp stock worth over $906,108,638 and over the last 21 years Isolde sold BRKR stock worth over $85,633,098.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Isolde Laukien BRKR stock SEC Form 4 insiders trading

Isolde has made over 3 trades of the Bruker Corp stock since 2004, according to the Form 4 filled with the SEC. Most recently Isolde sold 3,000,000 units of BRKR stock worth $28,080,000 on 22 September 2009.

The largest trade Isolde's ever made was selling 4,409,529 units of Bruker Corp stock on 26 February 2008 worth over $40,303,095. On average, Isolde trades about 2,810,716 units every 493 days since 2003. As of 22 September 2009 Isolde still owns at least 14,160,160 units of Bruker Corp stock.

You can see the complete history of Isolde Laukien stock trades at the bottom of the page.

What's Isolde Laukien's mailing address?

Isolde's mailing address filed with the SEC is , , , , .

Insiders trading at Bruker Corp

Over the last 21 years, insiders at Bruker Corp have traded over $527,877,336 worth of Bruker Corp stock and bought 5,273,190 units worth $50,472,973 . The most active insiders traders include Joerg C Laukien, Isolde Laukien a Marc M Laukien. On average, Bruker Corp executives and independent directors trade stock every 36 days with the average trade being worth of $16,426,809. The most recent stock trade was executed by Bob Rosenthal on 15 August 2024, trading 12,500 units of BRKR stock currently worth $292,125.

What does Bruker Corp do?

right from the beginning, which is now more than fifty years ago, bruker has been driven by a single idea: to provide the best technological solution for each analytical task. today, worldwide, more than 6,500 employees in over 90 locations on all continents are focusing their efforts on this permanent challenge. bruker systems cover a broad spectrum of applications in all fields of research and development and are used in all industrial production processes for the purpose of ensuring quality and process reliability. bruker continues to build upon its extensive range of products and solutions, expand its broad base of installed systems and maintain a strong reputation amongst its customers. as one of the world's leading analytical instrumentation companies, bruker remains focused on developing state-of-the-art technologies and innovative solutions for today’s ever complex analytical questions. bruker - innovation with integrity. bruker corporation company pages bruker axs: https://www

Complete history of Isolde Laukien stock trades at Bruker Corp

Bruker Corp executives and stock owners

Bruker Corp executives and other stock owners filed with the SEC include:

• Frank Laukien,
  Chairman of the Board, President, Chief Executive Officer
• Mark Munch,
  Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
• Juergen Srega,
  President of Bruker CALID Group and Bruker Daltonics Division
• Gerald Herman,
  Chief Financial Officer
• Dr. Frank H. Laukien Ph.D.,
  Chairman, CEO & Pres
• Burkhard Prause,
  President and Chief Executive Officer, Bruker Energy & Supercon Technologies, Inc
• Falko Busse,
  President, Bruker BioSpin Group
• Dr. Mark R. Munch Ph.D.,
  Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division
• Juergen Srega,
  Pres of Bruker CALID Group & Bruker Daltonics Division
• Gerald N. Herman,
  Exec. VP, CFO, Corp. Controller & Interim Head of IR
• Dr. Falko Busse Ph.D.,
  Pres of Bruker BioSpin Group
• John Ornell,
  Independent Director
• Richard Packer,
  Independent Director
• Robert Rosenthal,
  Independent Director
• Adelene Perkins,
  Independent Director
• William Linton,
  Lead Independent Director
• Marc Kastner,
  Independent Director
• Hermann Requardt,
  Independent Director
• Cynthia Friend,
  Independent Director
• Miroslava Minkova,
  Director, Investor Relations & Corporate Development
• Bonnie Anderson,
  Independent Director
• J. Brent Alldredge J.D.,
  Gen. Counsel
• Justin Joseph Ward,
  Sr. Director of Investor Relations & Corp. Devel.
• Kristin S. Caplice,
  Sec.
• Dr. Burkhard Prause,
  Pres and CEO of Bruker Energy & Supercon Technologies, Inc.
• Urban Faeh,
  Pres of Bruker Optics Division & Managing Director of Bruker Optik GmbH
• Stacey Desrochers,
  Treasurer & Director of Investor Relations
• Collin J. D'Silva,
  Pres of Chemical Analysis Division
• M Christopher Canavan,
  Director
• Richard Kniss,
  Director
• Ingen Chris Van,
  Director
• Stephen W. Fesik,
  Director
• Rene Lenggenhager,
  President, BioSpin Group
• Anthony L Mattacchione,
  Sr VP, Corp Fin & Accounting
• Gilles Gerard Jean Martin,
  Director
• Joerg C Laukien,
  10% owner
• Michael Gunnar Knell,
  Chief Accounting Officer
• Brenda J Furlong,
  Director
• Wolf Dieter Emmerich,
  Director
• Taylor Crouch,
  Director
• Bob Rosenthal,
  
• Laura Francis,
  Chief Financial Officer
• John Hulburt,
  Dir. of Audit /SEC Compliance
• Martin Haase,
  Senior Vice President
• Thomas Werner Bachmann,
  President Bruker BioSpin Group
• Charles F Jr Wagner,
  Director
• Bernhard Wangler,
  Director
• Bernd Gewiese,
  President, Bruker BioSpin Corp
• Werner Maas,
  President, Bruker BioSpin Corp
• Tony Werner Keller,
  Director
• Brian P Monahan,
  Corporate Controller
• Dirk D Laukien,
  10% owner
• Marc M Laukien,
  10% owner
• William J Knight,
  Chief Financial Officer
• Richard M Stein,
  Secretary
• Isolde Laukien,
  10% owner
• Collin J Dsilva,
  Director
• Philip Ma,